• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

GAP NARROWING BETWEEN FACIAL FILLERS

The FDA will review both Medicis Pharmaceutical Corp.'s Restylane and Inamed Corp's Hylaform on November 21.

Related Videos
Related Content
The Role of Medication in Effective Weight Loss
March 31st 2025

The Role of Medication in Effective Weight Loss

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 1st 2023

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

Novel Moisturizing Formulation is Effective for Repairing Skin After Microneedling
March 26th 2025

Novel Moisturizing Formulation is Effective for Repairing Skin After Microneedling

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

“Open Sandwich” Moisturization Regimen Does Not Affect Bioactivity of Retinols and Retinoids
March 24th 2025

“Open Sandwich” Moisturization Regimen Does Not Affect Bioactivity of Retinols and Retinoids

Do CBD Products Belong in Therapeutic Dermatology?
March 24th 2025

Do CBD Products Belong in Therapeutic Dermatology?

© 2025 MJH Life Sciences

All rights reserved.